Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025)
Achieve Life Sciences (ACHV) posted Operating Leases of $5000.0 for Q4 2025, down 76.19% on a QoQ basis from $21000.0 in Q3 2025, and down 92.42% year-over-year from $66000.0 in Q4 2024.
Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025) Analysis & Trends
Achieve Life Sciences' Operating Leases history runs 8 years deep, the most recent figure standing at $5000.0 for Q4 2025.
- Quarterly Operating Leases fell 92.42% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 92.42% YoY) and the FY2025 annual result came in at $5000.0, down 92.42% from the prior year.
- Operating Leases was $5000.0 for Q4 2025 at Achieve Life Sciences, down from $21000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $69000.0 in Q4 2022 and bottomed at $4000.0 in Q4 2021.
- A 5-year average of $35500.0 and a median of $37500.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases sank 94.81% — and 2022, when it soared 1625.0%.
- Achieve Life Sciences' Operating Leases stood at $4000.0 in 2021, then surged by 1625.0% to $69000.0 in 2022, then plunged by 91.3% to $6000.0 in 2023, then soared by 1000.0% to $66000.0 in 2024, then tumbled by 92.42% to $5000.0 in 2025.
- Business Quant data shows ACHV's Operating Leases at $5000.0 in Q4 2025, $21000.0 in Q3 2025, and $37000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 77,000.00 |
| Sep 30, 2020 | 94,000.00 |
| Jun 30, 2020 | 110,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Dec 31, 2019 | 159,000.00 |
| Sep 30, 2019 | 212,000.00 |